FDA Drug Recalls
723 recalls, newest first
Class II · Moderate risk Ongoing Mar 21, 2025
Reason Lack of Assurance of Sterility: Media fill with bacterial contamination
Class II · Moderate risk Ongoing Mar 21, 2025
Reason Lack of Assurance of Sterility: Media fill with bacterial contamination
Class II · Moderate risk Ongoing Mar 21, 2025
Reason Lack of Assurance of Sterility: Media fill with bacterial contamination
Class II · Moderate risk Ongoing Mar 17, 2025
Reason Failed dissolution specifications: lower than specifications
Class I · High risk Ongoing Mar 13, 2025
Reason LABELING: LABEL MIX-UP: The infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL, while the aluminum…
Class II · Moderate risk Ongoing Mar 13, 2025
Reason CGMP Deviations
Class II · Moderate risk Ongoing Mar 13, 2025
Reason CGMP Deviations
Class II · Moderate risk Ongoing Mar 13, 2025
Reason CGMP Deviations
Class II · Moderate risk Ongoing Mar 13, 2025
Reason CGMP Deviations
Class II · Moderate risk Ongoing Mar 13, 2025
Reason CGMP Deviations
Class II · Moderate risk Ongoing Mar 13, 2025
Reason CGMP Deviations
Class II · Moderate risk Ongoing Mar 13, 2025
Reason CGMP Deviations
Class II · Moderate risk Ongoing Mar 13, 2025
Reason CGMP Deviations
Class II · Moderate risk Ongoing Mar 13, 2025
Reason CGMP Deviations
Class II · Moderate risk Ongoing Mar 13, 2025
Reason CGMP Deviations
Class II · Moderate risk Ongoing Mar 13, 2025
Reason CGMP Deviations
Class II · Moderate risk Ongoing Mar 13, 2025
Reason CGMP Deviations
Class II · Moderate risk Ongoing Mar 13, 2025
Reason CGMP Deviations
Class II · Moderate risk Ongoing Mar 13, 2025
Reason CGMP Deviations
Class II · Moderate risk Ongoing Mar 13, 2025
Reason CGMP Deviations
Class II · Moderate risk Ongoing Mar 13, 2025
Reason CGMP Deviations
Class II · Moderate risk Ongoing Mar 13, 2025
Reason CGMP Deviations
Class II · Moderate risk Ongoing Mar 13, 2025
Reason CGMP Deviations
Class II · Moderate risk Ongoing Mar 13, 2025
Reason CGMP Deviations
Class II · Moderate risk Ongoing Mar 13, 2025
Reason CGMP Deviations